Alleviant Medical

Alleviant Medical, Inc. is a medical device company developing a no-implant atrial shunt for heart failure. The Alleviant System aims to relieve excess pressure in the heart through a one-time procedure, leaving no permanent implant. This minimally invasive approach is designed to treat both primary forms of heart failure.

Funding Round:

Funding Amount: $90M

Date: 14-Jan-2025

Investors: Gilde Healthcare, Omega Funds, S3 Ventures, RiverVest Venture Partners, Vensana Capital, Longview Ventures, Gilmartin Capital, TMC Venture Fund, undisclosed strategic investors

Markets: Medtech, Healthcare, Medical Devices, Interventional Cardiology, Heart Failure, HFpEF, HFmrEF, Congestive Heart Failure, Chronic Heart Failure, Structural Heart, Heart Failure with Preserved Ejection Fraction, Heart Failure with Mildly Reduced Ejection Fraction, Biotechnology, Clinical Trials

HQ: Austin, Texas, United States

Founded: 2017

Website: https://www.alleviantmedical.com

LinkedIn: https://www.linkedin.com/company/alleviant-medical

Twitter: https://twitter.com/alleviant

Instagram:

Facebook: https://www.facebook.com/alleviantmedical

Crunchbase: https://www.crunchbase.com/organization/alleviant-medical

Pitchbook: https://pitchbook.com/profiles/company/181403-47